🇺🇸 FDA
Patent

US 8399666

5-lipoxygenase-activating protein (FLAP) inhibitors

granted A61PA61P11/00A61P29/00

Quick answer

US patent 8399666 (5-lipoxygenase-activating protein (FLAP) inhibitors) held by Panmira Pharmaceuticals, LLC expires Mon Mar 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Panmira Pharmaceuticals, LLC
Grant date
Tue Mar 19 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61P, A61P11/00, A61P29/00, A61P9/00